TY - JOUR
T1 - Propionic acid induces cytoskeletal alterations in cultured astrocytes from rat cerebral cortex
AU - De Almeida, Lúcia Maria Vieira
AU - Funchal, Cláudia
AU - Gottfried, Carmem
AU - Wajner, Moacir
AU - Pessoa-Pureur, Regina
N1 - Funding Information:
Acknowledgments This work was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), PRONEX and Pró-Reitoria de Pesquisa e Pós-Graduac¸ão da Universidade Federal do Rio Grande do Sul (PROPESq-UFRGS).
PY - 2006/3
Y1 - 2006/3
N2 - Severe neurological symptoms, cerebral edema, and atrophy are common features of the inherited metabolic disorder propionic acidemia. However, the pathomechanisms involved in the neuropathology of this disease are not well established. In this study, we investigate the effects of propionic acid (PA), a metabolite accumulating in this disorder, on cytoskeletal reorganization, on cell viability, and on the in vitro phosphorylation of glial fibrillary acidic protein (GFAP) and vimentin in cultured astrocytes from cerebral cortex of neonatal rats. We observed that the astrocytes changed their usual polygonal morphology when exposed to 5 mM PA for 72 h, leading to the appearance of fusiform or process-bearing cells, without elicit cell death. We also noticed that after 72 h treatment with 5 mM PA cells showed retracted cytoplasm with bipolar processes containing packed GFAP filaments and disorganized actin stress fibers, as revealed by immunocytochemistry. In addition, the morphological alterations were accompanied by increased in vitro 32P incorporation into GFAP and vimentin recovered into the high-salt Triton-insoluble cytoskeletal fraction. In conclusion, our results indicate that PA lead to cytoskeletal reorganization and to increased in vitro phosphorylation of Triton-insoluble GFAP and vimentin. On the basis of our results we could suppose that Triton-insoluble GFAP and vimentin hyperphosphorylation could be implicated in the reorganization of cellular structure and these findings could be involved in the brain damage characteristic of propionic acidemia patients.
AB - Severe neurological symptoms, cerebral edema, and atrophy are common features of the inherited metabolic disorder propionic acidemia. However, the pathomechanisms involved in the neuropathology of this disease are not well established. In this study, we investigate the effects of propionic acid (PA), a metabolite accumulating in this disorder, on cytoskeletal reorganization, on cell viability, and on the in vitro phosphorylation of glial fibrillary acidic protein (GFAP) and vimentin in cultured astrocytes from cerebral cortex of neonatal rats. We observed that the astrocytes changed their usual polygonal morphology when exposed to 5 mM PA for 72 h, leading to the appearance of fusiform or process-bearing cells, without elicit cell death. We also noticed that after 72 h treatment with 5 mM PA cells showed retracted cytoplasm with bipolar processes containing packed GFAP filaments and disorganized actin stress fibers, as revealed by immunocytochemistry. In addition, the morphological alterations were accompanied by increased in vitro 32P incorporation into GFAP and vimentin recovered into the high-salt Triton-insoluble cytoskeletal fraction. In conclusion, our results indicate that PA lead to cytoskeletal reorganization and to increased in vitro phosphorylation of Triton-insoluble GFAP and vimentin. On the basis of our results we could suppose that Triton-insoluble GFAP and vimentin hyperphosphorylation could be implicated in the reorganization of cellular structure and these findings could be involved in the brain damage characteristic of propionic acidemia patients.
KW - Actin
KW - Cytoskeleton
KW - GFAP
KW - Phosphorylation
KW - Propionic acid
KW - Vimentin
UR - http://www.scopus.com/inward/record.url?scp=33745109858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745109858&partnerID=8YFLogxK
U2 - 10.1007/s11011-006-9002-9
DO - 10.1007/s11011-006-9002-9
M3 - Article
C2 - 16773470
AN - SCOPUS:33745109858
SN - 0885-7490
VL - 21
SP - 51
EP - 62
JO - Metabolic Brain Disease
JF - Metabolic Brain Disease
IS - 1
ER -